CellScape

CellScape Corporation is focused on developing a comprehensive non-invasive prenatal genetic test for women.

Funding reportedLast round: Series B

Biotechnology

Follow CellScape and see its new rounds in your feed.Start following

What company datasets say CellScape raised

Funding, as reported

Reported in all21.3Min the source's currency

Rounds6

Last roundSeries B

Last round dateMay 2013

Investors listed3

Investors who name them

Each firm lists CellScape on its own website. That is the firm's claim, a weaker thing than a round we watched, but a named source.

Startups like it

Add your raise, your deck and your story, and put CellScape in front of investors. Or tell us what we have wrong.